Remove Ablation Remove Atrial Fibrillation Remove Tachycardia
article thumbnail

Activation patterns and electrophysiological characteristics of Marshall Bundle related left atrial tachycardias post atrial fibrillation ablation

HeartRhythm

Epicardial Marshall bundle (MB) are frequently utilized in left atrial tachycardias (LATs) post atrial fibrillation (AF) ablation with pulmonary vein isolation and substrate modification.

article thumbnail

PO-05-084 BIATRIAL ATRIAL TACHYCARDIA DURING ABLATION OF SPATIOTEMPORAL DISPERSION ABLATION REGIONS IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION

HeartRhythm

Biatrial atrial tachycardia (BiAT) is a rare form of atypical macro-reentrant AT (MRAT) that can be difficult to characterize and ablate. Ablation of regions demonstrating spatiotemporal dispersion (SD) has shown a high rate of atrial fibrillation (AF) termination to either sinus or MRAT during ablation.

article thumbnail

PO-05-157 CHARACTERIZATION OF ATRIAL TACHYCARDIA FOLLOWING ABLATION OF SPATIOTEMPORAL DISPERSION ABLATION REGIONS IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION

HeartRhythm

Ablation of regions demonstrating spatiotemporal dispersion (SD) has been demonstrated as an alternative strategy beyond pulmonary vein isolation in patients with persistent atrial fibrillation. Occurrence of atrial tachycardia (AT) following ablation remains a limitation of this approach.

article thumbnail

Empirical superior vena cava electrical isolation guided by quantitative ablation index improves outcomes of radiofrequency catheter ablation for paroxysmal atrial fibrillation

Open Heart

Background The value of empirical superior vena cava isolation (SVCI) following pulmonary vein isolation (PVI) to improve the efficacy of radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation (PAF) remains controversial. RFCA was guided by quantitative AI in both groups. vs 81.5%, p=0.02). 95% CI 0.19

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.

article thumbnail

Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation

Frontiers in Cardiovascular Medicine

Typical atrial flutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. The data were obtained from a multicenter registry of cryoballoon ablation for AF ( n  = 2,689).

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.